Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : COVID-19 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : The EU Horizon 2020 Consortium
Deal Size : $0.9 million
Deal Type : Funding
ExpreS2ion announces EU grant award for the COVID-19 vaccine development programme
Details : The aim of the grant is to support the consortium in development of a COVID-19 vaccine candidate, including performing a Phase I/IIa clinical trial.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Undisclosed
June 03, 2020
Lead Product(s) : COVID-19 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : The EU Horizon 2020 Consortium
Deal Size : $0.9 million
Deal Type : Funding